QUANTIC NANOTECH Will Present the First Real Wearable for Osteoarthritis at CES 2019

Quantic nanotech osteoarthritis

QUANTIC NANOTECH, a product division of Spanish DEMAC S.A. group will present the first real wearable device for the treatment and prevention of osteoarthritis in Eureka Park at CES 2019.

The convenient and easy-to-use device is made for home use. Controlled by any smartphone or as standalone IoT device, the wearable enables remote monitoring by medical personnel.

Read more CES 2019 Healthcare Wearable: Exosystems exoRehab Gamifies Physical Therapy

“Three years ago, I was diagnosed with hand osteoarthritis. When I went to the hospital, I found the treatment so cumbersome and complicated that I decided to create a more simple and efficient solution for everyone,” said Jose Luis Torre DEMAC group CEO and author of many international related published patents.

The product won awards at various international shows like InPEX Pittsburgh, ITEX Indonesia and ‘Salon International des Inventions’ Geneva and integrates cutting-edge technologies like memory shaped alloys and latest generation materials, said a press release.

Quantic nanotech osteoarthritis
Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone. Rheumatism and osteoarthritis are the major causes of sick leave worldwide with USD$ 304 Billion of total medical and earning losses just in the US alone (Image: Wikimedia commons)

“The customized adaptation along with the possibility of applying topical treatments provided for this device can be very useful in hand osteoarthritis, said Dr. Juan Mulero MD Rheumatologist of the Ruber Internacional Hospital of Madrid. “This device is a way to apply at the same time and during the night several modalities of treatment in the osteoarthritic hand. This disease is very common, because according to the Framingham Osteoarthritis Study it produces in US symptoms of pain and deformity in 16% of women and in 8% of males. The local management of hand osteoarthritis combines both non-pharmacological and pharmacological approaches. Topical nonsteroidal anti-inflammatory drugs are recommended as a first-line pharmacological treatment, and splints might offer warmth, support and stabilization of joints,” he added.

Read more MANOVIVO: Wearable Smart Glove Offering Custom Support for People with Rheumatoid Arthritis

Our CEO Christian Stammel will attend CES 2019 and also be part of the conference track Wearable Tech Summit on January 9. The perfect sneak peek on what will be awaiting you at the WT | Wearable Technologies Conference EUROPE 2019 will give you a deep dive into the current momentum of the wearable market and how you can turn the previous hype into mass volume. Our 33rd edition of the WT Conference will be bigger than ever with more than 1.500 m2 floor space and over 80.000 visitors from WT and ISPO integrated into the brand-new innovation hall C6 of the Munich Tradeshow. More than 60 high-level speakers coming from Bayer, BMW, Casio, Gore, Microsoft, and STMicroelectronics will give you latest insights in their applications and digitalization strategies via IoT and WT solutions and drive your business development. In the afternoon of the first day, you will get also the chance to be connected to 30 future stars of our ecosystem via our annual IOT/WT INNOVATION WORLD CUP® pitch and award ceremony.

Register here https://www.wearable-technologies.eu/

Previous articleCES 2019 Healthcare Wearable: Exosystems exoRehab Gamifies Physical Therapy
Next articleHealth Trends at the CES 2019 will be AR, AI-Driven Health Solutions
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)wearable-technologies.com.